2m 2m 2m 2m 2m 2m 2m
ATAI BECKLEY (ATAI)
NASDAQ
$4.17+$0.12 (+3.01%)
Price as of Jun 23, 2026 1:36 PM EDT- $1.5BMarket Cap
- 100.50%1-Year Change
- BiotechnologyIndustry
ATAI BECKLEY (ATAI)
$4.17+$0.12 (+3.01%)
Annual
Quarterly
12/31/2025 | ||
|---|---|---|
Income Statement | ||
Total Operating Revenue | 0 N/A | |
Cost of Revenue | N/A N/A | |
Gross Profit | 0 N/A | |
Sales and Marketing Expense | N/A N/A | |
Research and Development Expense | -53.1M N/A | |
Depreciation and Amortization Expense | 1.0M N/A | |
Total Operating Expenses | 648.1M N/A | |
Operating Profit | -644.1M N/A | |
Interest Income | 1.5M N/A | |
Interest Expense | N/A N/A | |
Interest Income and Expense and Net | 1.5M N/A | |
Total Nonoperating Income and Expense | -15.8M N/A | |
Income before Taxes | -659.8M N/A | |
Income Taxes | 298,000 N/A | |
Extraordinary Items | N/A N/A | |
Net Income | 4.8M N/A | |
Net Income from Continuing Operations Applicable to Common | 4.8M N/A | |
Basic EPS and Net Income | -2.91 N/A | |
Diluted EPS and Net Income | -2.91 N/A | |
Basic Weighted Average Shares | 226.5M N/A | |
Diluted Weighted Average Shares | 226.5M N/A | |
Balance Sheet | ||
Cash and Cash Equivalents | 85.3M N/A | |
Short-Term Investments | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 85.3M N/A | |
Total Current Assets | 275.7M N/A | |
Accumulated Depreciation | 405,000 N/A | |
Property and Plant and Equipment and Net | 2.2M N/A | |
Total Long-Term Assets | 1.1M N/A | |
Total Assets | 292.7M N/A | |
Income Taxes Payable | 156,000 N/A | |
Total Short-Term Debt | 0 N/A | |
Total Current Liabilities | 23.5M N/A | |
Total Long-Term Debt | 0 N/A | |
Total Long-Term Liabilities | 754,000 N/A | |
Total Liabilities | 70.7M N/A | |
Retained Earnings | -1.4B N/A | |
Total Stockholders Equity | 221.9M N/A | |
Total Shares Outstanding | 363.3M N/A | |
Cash Flow | ||
Cash from Operating Activities | -102.7M N/A | |
Capital Expenditures | 901,000 N/A | |
Cash from Investing Activities | -109.1M N/A | |
Dividends Paid | N/A N/A | |
Cash from Financing Activities | 269.5M N/A | |
Financials Ratio | ||
Gross Margin | N/A N/A | |
Operating Margin | N/A N/A | |
Return on Assets | N/A N/A | |
Return on Equity | N/A N/A | |
Revenue Growth | N/A N/A | |
Current Ratio | N/A N/A | |
Cash Ratio | N/A N/A | |
Debt-to-Equity Ratio | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow